Sep252019UncategorizedCategory: UncategorizedBy Charlotte Maddalena25 September 2019Leave a comment Author: Charlotte Maddalena Post navigationPreviousPrevious post:ORPHELIA announces Orphan Drug Designation for Kimozo®NextNext post:Two new projects supported by our Endowment FundRelated PostsNewsletter July 20206 July 2020Alizé Pharma 3 Announces Rebranding to Amolyt Pharma4 June 2020Nine new projects supported by our Foundation14 May 2020ORPHELIA Pharma recrute un/une Chargé Assurance Qualité20 April 2020Newsletter april 202019 April 2020Three new projects supported by our Foundation20 March 2020
